US$ 21.60
semaglutide and ketosis A Multidisciplinary Perspective on Semaglutide Treatment and Medical Nutrition Therapy in Obesity Management Implementing the Solution with SuperSlim
Description
RCT, randomized clinical trial

Metabolism (2005) 54:82934

Which one is better for GLP-1 users

Semaglutide can help people lose an average of 18% of their body weight at the highest dose (Wegovy 7.2 mg), and tirzepatide has been associated with an average of 21% at the 15 mg dose of Zepbound

Figure S6: (A) Overview of risk of bias, (B) Detailed risk of bias in each study
